When Temasek Begins Negotiations, The Cloudnine Hospital Network May Obtain An Investment Opportunity in 2023, According To A Report.

The Indian hospital chain, Cloudnine Hospitals, is reportedly in advanced discussions with Singaporean sovereign fund Temasek Holdings to sell a minority stake, according to an article published on Thursday. The deal would value the hospital chain at approximately Rs 30 billion ($362.7 million).

Citing two sources familiar with the matter, the report revealed that Temasek is expected to invest around Rs 5 billion for a 15% to 20% stake in the Bengaluru-based company through its Sheares Healthcare unit. Meanwhile, existing investor NewQuest Capital is set to increase its stake in Cloudnine Hospitals with an investment of approximately Rs 2 billion.

Cloudnine Hospitals is primarily focused on offering maternity, gynaecology, and pediatric healthcare services. The hospital chain has been rapidly expanding its presence across India and operates a network of over 30 hospitals in the country.

If the deal goes through, it will be Temasek’s latest investment in the Indian healthcare industry. The Singaporean fund has previously invested in companies such as Manipal Hospitals, Medanta, and Cipla Health, among others.

Singapore investment firm Temasek, along with Cloudnine and NewQuest, have failed to respond to multiple requests for comments from Reuters. It has been reported that Cloudnine had previously intended to launch an initial public offering in February of last year with the goal of raising Rs 12 billion. However, the plan was postponed due to market instability at the time.

About Cloudnine:

Cloudnine is a prominent network of healthcare facilities in India that focuses on the provision of quality care for women, children, and married couples who are experiencing fertility problems. The company has its headquarters in Bengaluru and operates 23 centers across the country, with nine hospitals in Bengaluru, as well as centers in Gurgaon, Noida, Chandigarh, Panchkula, New Delhi, Faridabad, Chennai, Mumbai, and Pune.

The company’s commitment to providing top-notch medical services and personalized care has earned it a reputation as one of India’s most notable healthcare providers. With a team of highly skilled and experienced medical professionals, Cloudnine has helped thousands of patients achieve their desired health outcomes, particularly in the areas of women’s and children’s health, as well as fertility treatments.

Cloudnine’s focus on women’s health is evident in the services it provides, which include obstetrics and gynaecology, neonatology, pediatrics, and fertility treatments. The company’s centers are equipped with state-of-the-art medical equipment and facilities to ensure that patients receive the best possible care.

Cloudnine’s expansion across the country has been fueled by the growing demand for specialized healthcare services, particularly in the areas of women’s and children’s health and fertility treatments. The company’s commitment to delivering quality care and personalized services has enabled it to establish a strong presence in the healthcare industry.

Cloudnine’s success in providing exceptional healthcare services has earned it numerous accolades, including the “Best Maternity Hospital” award at the India Healthcare Awards in 2020. With a continued focus on excellence, Cloudnine is poised to remain at the forefront of healthcare provision in India.

About Temasek:

Temasek Holdings (Private) Limited, a state-holding firm controlled by the Singaporean government, is a renowned global investment company. According to its latest report released in December 2022, the company manages and owns assets valued at US$496.59 billion (S$671 billion), an increase from its previous year’s total investment worth US$287 billion (S$403 billion).

Temasek, formed on June 25th, 1974, boasts an impressive track record with a one-year total shareholder return (TSR) of 5.8 percent, 7 percent and 8 percent compounded yearly for 10 to 20-year TSRs, respectively. Over 48 years, its TSR compounded to an impressive 14 percent.

In 2004, Temasek received its first-ever credit ratings and has since maintained “Aaa/AAA” scores from Moody’s and Standard & Poor’s, respectively, showcasing its excellent creditworthiness.

The Linaburg-Maduell Transparency Index, which assesses the transparency of government-owned investment funds, has consistently ranked Temasek favorably. The company’s portfolio is widely diversified, with a 60 percent underlying exposure to advanced economies and strong roots in Asia.

Temasek’s investments have a significant impact on the global economy, and with its impressive performance, the company remains a top choice for global investors seeking reliable investment opportunities.

Edited by Prakriti Arora